Human immunodeficiency virus 1 Vpu protein does not affect the conversion of influenza a virus hemagglutinin to its low-pH conformation in an acidic trans-Golgi compartment

Acta Virologica

Volumn 54, Issue 3, 2010, Pages 197-203

  Betakova T ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

Human immunodeficiency virus 1; Influenza A virus; Ion channel; M2 protein; Vpu protein

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; ION CHANNEL; PROTEIN M2; VPU PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; VIRUS PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ACIDITY; ANIMAL CELL; ARTICLE; CHANNEL GATING; CONFORMATIONAL TRANSITION; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; INTRACELLULAR TRANSPORT; NONHUMAN; PH; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; TRANS GOLGI NETWORK; ANIMAL; CELL LINE; CELL MEMBRANE; CERCOPITHECUS; CHEMISTRY; GENETICS; HELA CELL; HUMAN; METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA A VIRUS;

ANIMALS; CELL LINE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; HELA CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; PROTEIN CONFORMATION; PROTEIN TRANSPORT; TRANS-GOLGI NETWORK; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 78049489611     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2010_03_197     Document Type: Article

References (49)

1. Betakova T, Ciampor F, Hay AJ (2005): Influence of residue 44 on the activity of the M2 proton channel of influenza A virus. J. Gen. Virol. 86, 181-184. doi:10.1099/vir.0.80358-0
2. Betáková T, Kollerová E (2006): pH modulating activity of ion channels of influenza A, B, and C viruses. Acta Virol. 50, 187-193.
3. Betakova T, Hay AJ (2007): Evidence that the CM2 protein of influenza C virus can modify the pH of the exocytic pathway of transfected cells. J. Gen. Virol. 88, 2291-226. doi:10.1099/vir.0.82785-0
4. Betakova T, Hay AJ (2009): Comparison of the activities of BM2 protein and its H19 and W23 mutants of influenza B virus with activities of M2 protein and its H37 and W41 mutants of influenza A virus. Arch. Virol. 154, 1619-1624. doi:10.1007/s00705-009-0483-9
5. Barco A, Carrasco L (1995): A human virus protein, poliovirus protein 2BC, induces membrane proliferation and blocks the exocytic pathway in the yeast Saccharomyces cerevisiae. EMBO J. 14, 3349-3364.
6. Bour S, Strebel K (2003): The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release. Microbes Infect. 5, 1029-1039. doi:10.1016/S1286-4579(03)00191-6
7. Ciampor F, Bayley PM, Nermut MV, Hirst EM, Sugrue RJ, Hay AJ (1992): Evidence that the amantadine-induced M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans-Golgi compartment. Virology 188, 14-24. doi:10.1016/0042-6822(92)90730-D
8. Chizhmakov IV, Geraghty FM, Ogden DC, Hayhurst A, Antoniou M, Hay AJ (1996): Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukemia cells. J. Phiosiol. 494, 329-336.
9. Cohen EA, Terwilliger EF, Sodroski JG, Haseltine WA (1988): Identification of a protein encoded by the vpu gene of HIV-1. Nature 334, 532-534. doi:10.1038/334532a0
10. Dubé M, Roy BB, Guiot-Guillain P, Mercier J, Binette J, Leung G, Cohen EA (2009): Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 83, 4574-4590. doi:10.1128/JVI.01800-08
11. Ewart GD, Sutherland T, Gage PW, Cox GB (1996): The Vpu protein of human immunodeficiency virus type 1 forms cationselective ion channels. J. Virol. 70, 7108-7115.
12. Fuerst TR, Niles EG, Studier FW, Moss B (1986): Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83, 8122-8126. doi:10.1073/pnas.83.21.8122
13. Grambas S, Bennet MS, Hay AJ (1992): Influence of amantadine resistance mutations on the pH encoutered during transport and its regulation by the M2 protein. Virology 191, 541-549. doi:10.1016/0042-6822(92)90229-I
14. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH (1985): The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4, 3021-3024.
15. Hay AJ (1992): The action of adamantadines against influenza A viruses: Inhibition of the M2 ion channel protein. Semin. Virol. 3, 21-30.
16. Helenius A (1992): Unpacking the incoming influenza virus. Cell 69, 577-578.
17. Henkel JR, Popovich JL, Gibson GA, Watkins SC, Weisz OA (1999): Selective perturbation of early endosome and/or trans-Golgi network pH but not lysosome pH by dose-dependent expression of influenza M2 pro tein. J. Biol. Chemistry 274, 9854-9860. doi:10.1074/jbc.274.14.9854
18. Holsinger LJ, Lamb RA (1991): Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 183, 32-43. doi:10.1016/0042-6822(91)90115-R
19. Hout DR, Mulcahy ER, Pacyniak E, Gomez LM, Gomez ML, Stephens EB (2004): Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1. Curr. HIV Res. 2, 255-270. doi:10.2174/1570162043351246
20. Hout DR, Gomez LM, Pacyniak E, Miller JM, Hill MS, Stephens EB (2006a): A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine. Virology 348, 449-461. doi:10.1016/j.virol.2005.12.025
21. Hout DR, Gomez ML, Pacyniak E, Gomez LM, Fegley B, Mulcahy ER, Hill MS, Culley N, Pinson DM, Nothnick W, Powers MF, Wong SW, Stephens EB (2006b): Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques. Virology 344, 541-559. doi:10.1016/j.virol.2005.08.022
22. Hughey PG, Compans RW, Zebedee SL, Lamb RA (1992): Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J. Virol. 66, 5542-552.
23. Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM (1990): The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64, 621-629.
24. Lamb RA, Zebedee SL, Richardson CD (1985): Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40, 627-633.
25. Marassi FM, Ma C, Gratkowski H, Straus SK, Strebel K, Oblatt-Montal M, Montal M, Opella SJ (1999): Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proc. Natl. Acad. Sci. USA 96, 14336-1441. doi:10.1073/pnas.96.25.14336
26. Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R (1998): A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell. 1, 565-574. doi:10.1016/S1097-2765(00)80056-8
27. McCormick-Davis C, Dalton SB, Singh DK, Stephens EB (2000): Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates. AIDS Res. Hum. Retrovir. 16, 1089-1095. doi:10.1089/08892220050075363
28. Mehnert T, Routh A, Judge PJ, Lam YH, Fischer D, Watts A, Fischer WB (2008): Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism. Proteins 70, 1488-1497. doi:10.1002/prot.21642
29. Mould JA, Drury JE, Frings SM, Kaupp UB, Pekosz A, Lamb RA, Pinto LH (2000): Permeation and activation of the M2 ion channel of influenza A virus. J. Biol. Chem. 275, 31038-31050. doi:10.1074/jbc.M003663200
30. Mould JA, Paterson RG, Takeda M, Ohigashi Y, Venkataraman P, Lamb RA, Pinto LH (2003): Influenza B virus BM2 protein has an ion channel activity that conducts protons across membranes. Dev. Cell 5, 175-184. doi:10.1016/S1534-5807(03)00190-4
31. Ohuchi M, Cramer A, Vey M, Ohuchi R, Garden W, Klenk H-D (1994): Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J. Virol. 68, 920-926.
32. Park SH, Opella SJ (2007): Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs. Protein Sci. 16, 2205-2215. doi:10.1110/ps.073041107
33. Pinto LH, Holsinger LJ, Lamb RA (1992): Influenza A virus M2 protein has an ion channel activity. Cell 69, 517-528.
34. Premkumar A, Ewart GD, Cox GB, Gage PW (2004): An aminoacid substitution in the influenza-B NB protein affects ion-channel gating. J. Membr. Biol. 197, 135-143. doi:10.1007/s00232-004-0648-0
35. Römer W, Lam YH, Fischer D, Watts A, Fischer WB, Göring P, Wehrspohn RB, Gösele U, Steinem C (2004): Channel activity of a viral transmembrane peptide in micro-BLMs: Vpu(1-32) from HIV-1. J. Am. Chem. Soc. 126, 16267-1674. doi:10.1021/ja0451970
36. Sakaguchi T, Leser GP, Lamb RA (1996): The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J. Cell. Biol. 133, 733-747. doi:10.1083/jcb.133.4.733
37. Sugrue RJ, Bahadur G, Zambon MC, Hall-Smith M, Douglas AR, Hay AJ (1990): Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 9, 3469-3476.
38. Sugrue RJ, Hay AJ (1991): Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180, 617-624. doi:10.1016/0042-6822(91)90075-M
39. Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, Porstmann T (1994): The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J. Mol. Biol. 236, 16-25. doi:10.1006/jmbi.1994.1114
40. Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, Strebel K (1996a): The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70, 809-819.
41. Schubert U, Ferrer-Montiel AV, Oblatt-Montal M, Henklein P, Strebel K, Montal M (1996b): Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 398, 12-18. doi:10.1016/S0014-5793(96)01146-5
42. Schubert U, Antón LC, Bacík I, Cox JH, Bour S, Bennink JR, Orlowski M, Strebel K, Yewdell JW (1998): CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72, 2280-2288.
43. Schwartz S, Felber BK, Fenyö EM, Pavlakis GN (1990): Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol. 64, 5448-5456.
44. Strebel K, Klimkait T, Martin MA (1988): A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241, 1221- 1223. doi:10.1126/science.3261888
45. Strebel K, Klimkait T, Maldarelli F, Martin MA (1989): Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J. Virol. 63, 3784-3791.
46. Sunstrom NA, Premkumar LS, Prenkumar A, Ewart G, Cox GB, Gage PW (1996): Ion channel formed by NB, an influenza B virus protein. J. Membr. Biol. 150, 127-132. doi:10.1007/s002329900037
47. Terwilliger EF, Cohen EA, Lu YC, Sodroski JG, Haseltine WA (1989): Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. USA 86, 5163-5137. doi:10.1073/pnas.86.13.5163
48. Van Damme N, Guatelli J (2008): HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gagcontaining endosomes. Cell Microbiol. 10, 1040-1057. doi:10.1111/j.1462-5822.2007.01101.x
49. Willey RL, Maldarelli F, Martin MA, Strebel K (1992): Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-200.